Enolen is currently being studied in a Phase 1 trial evaluating its safety, tolerability and preliminary efficacy for localized sustained delivery of enzalutamide into the prostate. Alessa expects to ...

Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical results published Aug ...

Preventive health care encompasses a host of strategies designed to reduce individuals’ risk for conditions and diseases that can adversely affect their quality of life. Routine exercise and a ...

(WXYZ) — In today's health alert, the second leading cause of cancer-related deaths among men worldwide may soon have a promising new treatment. Biontech has ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced several regulatory actions. Here is an overview of decisions that may be relevant to your ...

BUFFALO, N.Y. – Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical ...